Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.

Huang, Q Sue; Wood, Tim; Jelley, Lauren; Jennings, Tineke; Jefferies, Sarah; Daniells, Karen; Nesdale, Annette; Dowell, Tony; Turner, Nikki; Campbell-Stokes, Priscilla; Balm, Michelle; Dobinson, Hazel C; Grant, Cameron C; James, Shelley; Aminisani, Nayyereh; Ralston, Jacqui; Gunn, Wendy; Bocacao, Judy; Danielewicz, Jessica; Moncrieff, Tessa; McNeill, Andrea; Lopez, Liza; Waite, Ben; Kiedrzynski, Tomasz; Schrader, Hannah; Gray, Rebekah; Cook, Kayla; Currin, Danielle; Engelbrecht, Chaune; Tapurau, Whitney; Emmerton, Leigh; Martin, Maxine; Baker, Michael G; Taylor, Susan; Trenholme, Adrian; Wong, Conroy; Lawrence, Shirley; McArthur, Colin; Stanley, Alicia; Roberts, Sally; Rahnama, Fahimeh; Bennett, Jenny; Mansell, Chris; Dilcher, Meik; Werno, Anja; Grant, Jennifer; van der Linden, Antje; Youngblood, Ben; Thomas, Paul G; NPIsImpactOnFlu Consortium; Webby, Richard J

dc.contributor.author	Huang, Q Sue
dc.contributor.author	Wood, Tim
dc.contributor.author	Jelley, Lauren
dc.contributor.author	Jennings, Tineke
dc.contributor.author	Jefferies, Sarah
dc.contributor.author	Daniells, Karen
dc.contributor.author	Nesdale, Annette
dc.contributor.author	Dowell, Tony
dc.contributor.author	Turner, Nikki
dc.contributor.author	Campbell-Stokes, Priscilla
dc.contributor.author	Balm, Michelle
dc.contributor.author	Dobinson, Hazel C
dc.contributor.author	Grant, Cameron C
dc.contributor.author	James, Shelley
dc.contributor.author	Aminisani, Nayyereh
dc.contributor.author	Ralston, Jacqui
dc.contributor.author	Gunn, Wendy
dc.contributor.author	Bocacao, Judy
dc.contributor.author	Danielewicz, Jessica
dc.contributor.author	Moncrieff, Tessa
dc.contributor.author	McNeill, Andrea
dc.contributor.author	Lopez, Liza
dc.contributor.author	Waite, Ben
dc.contributor.author	Kiedrzynski, Tomasz
dc.contributor.author	Schrader, Hannah
dc.contributor.author	Gray, Rebekah
dc.contributor.author	Cook, Kayla
dc.contributor.author	Currin, Danielle
dc.contributor.author	Engelbrecht, Chaune
dc.contributor.author	Tapurau, Whitney
dc.contributor.author	Emmerton, Leigh
dc.contributor.author	Martin, Maxine
dc.contributor.author	Baker, Michael G
dc.contributor.author	Taylor, Susan
dc.contributor.author	Trenholme, Adrian
dc.contributor.author	Wong, Conroy
dc.contributor.author	Lawrence, Shirley
dc.contributor.author	McArthur, Colin
dc.contributor.author	Stanley, Alicia
dc.contributor.author	Roberts, Sally
dc.contributor.author	Rahnama, Fahimeh
dc.contributor.author	Bennett, Jenny
dc.contributor.author	Mansell, Chris
dc.contributor.author	Dilcher, Meik
dc.contributor.author	Werno, Anja
dc.contributor.author	Grant, Jennifer
dc.contributor.author	van der Linden, Antje
dc.contributor.author	Youngblood, Ben
dc.contributor.author	Thomas, Paul G
dc.contributor.author	NPIsImpactOnFlu Consortium
dc.contributor.author	Webby, Richard J
dc.coverage.spatial	England
dc.date.accessioned	2021-04-19T22:55:25Z
dc.date.available	2021-04-19T22:55:25Z
dc.date.issued	2021-2-12
dc.identifier.citation	Nature communications 12(1):1001 12 Feb 2021
dc.identifier.issn	2041-1723
dc.identifier.uri	https://hdl.handle.net/2292/54920
dc.description.abstract	Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave. Using multiple surveillance systems, we observed a parallel and unprecedented reduction of influenza and other respiratory viral infections in 2020. This finding supports the use of these NPIs for controlling pandemic influenza and other severe respiratory viral threats.
dc.format.medium	Electronic
dc.language	eng
dc.publisher	Springer Science and Business Media LLC
dc.relation.ispartofseries	Nature communications
dc.rights	Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri	https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/
dc.subject	NPIsImpactOnFlu Consortium
dc.subject	Humans
dc.subject	Respiratory Tract Infections
dc.subject	Hospitalization
dc.subject	Public Health
dc.subject	Communicable Disease Control
dc.subject	New Zealand
dc.subject	Influenza, Human
dc.subject	Pandemics
dc.subject	Epidemiological Monitoring
dc.subject	COVID-19
dc.subject	SARS-CoV-2
dc.subject	COVID-19
dc.subject	Communicable Disease Control
dc.subject	Epidemiological Monitoring
dc.subject	Hospitalization
dc.subject	Humans
dc.subject	Influenza, Human
dc.subject	New Zealand
dc.subject	Pandemics
dc.subject	Public Health
dc.subject	Respiratory Tract Infections
dc.subject	SARS-CoV-2
dc.title	Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.
dc.type	Journal Article
dc.identifier.doi	10.1038/s41467-021-21157-9
pubs.issue	1
pubs.begin-page	1001
pubs.volume	12
dc.date.updated	2021-03-11T22:37:28Z
dc.rights.holder	Copyright: The authors	en
pubs.author-url	https://www.ncbi.nlm.nih.gov/pubmed/33579926
pubs.publication-status	Published
dc.rights.accessrights	http://purl.org/eprint/accessRights/OpenAccess	en
pubs.subtype	Research Support, U.S. Gov't, P.H.S.
pubs.subtype	Research Support, Non-U.S. Gov't
pubs.subtype	research-article
pubs.subtype	Journal Article
pubs.subtype	Research Support, N.I.H., Extramural
pubs.subtype	Observational Study
pubs.elements-id	838735
dc.identifier.eissn	2041-1723
dc.identifier.pii	10.1038/s41467-021-21157-9
pubs.number	1001
pubs.online-publication-date	2021-2-12